bpc-157 safety human studies side effects BPC-157: Experimental Peptide Creates Risk for Athletes bpc-157 safety human trials adverse
Description
Retatrutide is an investigational drug not yet approved by the FDA
Which is better
What those studies consistently show is that BPC-157 activates several interconnected healing pathways including growth factor signaling, angiogenesis (new blood vessel formation), and anti-inflammatory cascades
Its reported biological effects have been investigated primarily in cell culture systems, tissue-level experimental models, and laboratory animal models, rather than in validated clinical settings
